Preeclampsia: Symptoms, Risks, Pathophysiology, and Management

Preeclampsia is a hypertensive disorder of pregnancy defined by new-onset hypertension (≥140/90 mmHg) after 20 weeks' gestation accompanied by proteinuria (≥300 mg/24h or protein/creatinine ratio ≥0.3) or other signs of end-organ dysfunction (thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, cerebral/visual symptoms).

Maternal and Fetal Risks

  • Preterm birth (iatrogenic or spontaneous) and low birth weight.
  • Eclampsia: Generalized tonic-clonic seizures—obstetric emergency.
  • HELLP syndrome: Hemolysis, Elevated Liver enzymes, Low Platelets—severe variant.
  • Placental abruption: Premature separation → fetal distress, maternal hemorrhage.
  • Fetal growth restriction (IUGR) and stillbirth from placental insufficiency.
  • Long-term maternal risk: 2-4× increased lifetime cardiovascular disease (hypertension, ischemic heart disease, stroke).

Pathophysiology: The Placental Connection

Preeclampsia originates from abnormal trophoblast invasion and spiral artery remodeling in early pregnancy (first trimester). Inadequate conversion of high-resistance spiral arteries to low-resistance uteroplacental vessels leads to:

  1. Placental hypoxia/ischemia and oxidative stress.
  2. Release of anti-angiogenic factors (sFlt-1, soluble endoglin) into maternal circulation.
  3. Systemic endothelial dysfunction → vasoconstriction, capillary leak, coagulation activation, inflammation.
  4. Clinical syndrome: hypertension, proteinuria, end-organ involvement.

Management Strategies

Expectant Management (Preterm, Stable)

  • Close maternal-fetal surveillance: BP monitoring, labs (CBC, LFTs, creatinine, uric acid), fetal growth/well-being (NST, BPP, Doppler).
  • Antihypertensives for severe-range BP (≥160/110): labetalol, nifedipine, methyldopa.
  • Corticosteroids (betamethasone) for fetal lung maturity if <34 weeks.
  • Magnesium sulfate for seizure prophylaxis if severe features or during delivery.

Definitive Treatment: Delivery

  • ≥37 weeks: Delivery recommended.
  • 34-36+6 weeks: Delivery if severe features or maternal/fetal instability; otherwise individualized.
  • <34 weeks: Expectant management if stable; delivery for severe features, fetal compromise, or 34 weeks reached.

Postpartum Care

  • Preeclampsia can develop or worsen postpartum (up to 6 weeks).
  • BP monitoring, magnesium continuation (24h postpartum if given), antihypertensive titration.
  • Cardiovascular risk counseling and long-term follow-up.

Multidisciplinary care (OB, MFM, nephrology, cardiology, neonatology) optimizes outcomes. Patient education on warning signs (severe headache, visual changes, epigastric pain, sudden swelling) empowers timely reporting. Preeclampsia remains a leading cause of maternal and perinatal morbidity—vigilance saves lives.

Genetic Disorders - Related Articles